Cardiosense
Chicago, US · Founded 2020 · Delaware corporation · 7 known investors
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management. Its FDA De Novo-cleared platform supports pressure-guided heart failure management for clinicians across hospital and home care settings.
AI & Machine LearningDigital HealthMedical Devices
Founders & leadership
Cardiosense was founded in 2020 by Amit K. Gupta.
AK
Amit K. GuptaFounder
OT
Omer Tolga InanNamed on SEC filing
AM
Andrew Michael CarekNamed on SEC filing
OI
Omer InanCo-founder, Chief Scientific Officer
AC
Andrew CarekCo-founder, Chief Technical Officer
AG
Amit GuptaCo-founder, Advisor (former founding CEO)
ME
Mozziyar EtemadiCo-founder, Head of AI
EM
Eric MeizlishChief Executive Officer
JD
John D. MartinChief Medical Officer
AA
Arezou AzarChief Regulatory & Compliance Officer
Board
JT
DG
Investors · 7
Reported raises · per SEC filings
Form D private placements$9.1M disclosed across 1 round · 2022
▶$9.1MraisedDec 2022 · 28 investors · OtherRule 506(b)
▶$9.1MraisedDec 2022 · 28 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jeff TerrellDirector
- Omer Tolga InanDirector
- Amit K. GuptaExecutive Officer, Director
- Andrew Michael CarekExecutive Officer
- Daniel GottliebDirector
- Offering amount
- $17.7M
- Amount sold
- $9.1M
- Minimum investment
- $20K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlapRf Surgical43 shared keywordsMedtronic develops healthcare technology, including pulsed field ablation systems used to treat atrial fibrillation (AFib). The company serves clinicians and healthcare providers in the medical device and cardiac care field.
Abbott37 shared keywordsAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
Massdevice34 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
AliveCor34 shared keywordsAliveCor develops digital health solutions focused on cardiovascular care, serving employers and healthcare payers seeking enterprise heart health platforms.
Digital32 shared keywordsDigital.Health is a clinician-curated discovery platform where clinicians, health systems, and consumers find, compare, and select digital health solutions. It offers structured company and product listings that feed its comparison engine, recommendation system, and AI-enabled search for buyers in active evaluation.
Boston Scientific25 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Cardiac Insight Inc.18 shared keywordsCardiac Insight develops handheld and wearable ECG devices for cardiac diagnostics, including the Cardea 20/20 for athlete heart screening and the Cardea SOLO for 7-day ambulatory monitoring. The company serves healthcare providers and patients seeking reliable electrocardiogram analysis and cardiac evaluation.
Companies competing with Cardiosense for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cardiosense do?
- Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management. Its FDA De Novo-cleared platform supports pressure-guided heart failure management for clinicians across hospital and home care settings.
- Who founded Cardiosense?
- Cardiosense was founded by Amit K. Gupta in 2020.
- Who are Cardiosense's investors?
- Cardiosense's investors include BayMed Venture Partners, Broadview Ventures, Cross-Border Impact Ventures, Laerdal Million Lives Fund, OSF Ventures, Portal Innovations, Hatteras Venture Partners.
- How much funding has Cardiosense raised?
- Cardiosense has disclosed $9.1M raised across 1 round.
- Where is Cardiosense headquartered?
- Cardiosense is headquartered in Chicago, US.